home / stock / bsm / bsm message board
Subject | By | Source | When |
---|---|---|---|
Black Stone Minerals (NYSE:$BSM): Q2 EPS of -$0.56 Revenue | Timothy Smith | investorshub | 08/13/2015 12:44:17 AM |
Black Stone Minerals (Pending:BSM): Q1 EPS of $0.09 | Timothy Smith | investorshub | 06/04/2015 12:33:01 PM |
0,275 + 36,68% | harmsen | investorshub | 01/22/2015 6:58:24 PM |
+ 34,15% | harmsen | investorshub | 01/22/2015 6:37:48 PM |
Here we go! | harmsen | investorshub | 01/22/2015 6:09:05 PM |
Nice volume today,price 0,26!!!! | harmsen | investorshub | 01/22/2015 6:04:07 PM |
BSM Wouldnt you think every hospital in the | vandad | investorshub | 09/02/2005 1:08:13 PM |
THAT is the 100.00 question............ | olico â„¢ | investorshub | 09/01/2005 4:54:58 AM |
Will they be making any money? | JerryinCT | investorshub | 09/01/2005 1:56:26 AM |
BOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!! | olico â„¢ | investorshub | 08/31/2005 8:37:03 PM |
News, Short Squeeze, Breakout and More Instantly...
Black Stone Minerals L.P. representing limited partner interests Company Name:
BSM Stock Symbol:
NYSE Market:
Black Stone Minerals L.P. representing limited partner interests Website:
Black Stone Minerals, L.P. (NYSE: BSM) (“Black Stone,” “BSM,” “the Company,” or “the Partnership”) today declared the distribution attributable to the fourth quarter of 2024. Additionally, the Partnership announced the date of its fourth qua...
2024-11-05 19:09:17 ET In a landscape marked by fluctuating oil prices, the company has seen revenue rise steadily, reflecting effective strategies and market demand. Operating expenses have also increased, indicating growing operational demands. Management remains focused on navigating indus...
Aclaris Therapeutics Inc. (ACRS) is expected to report $-0.08 for Q3 2024 Crawford & Company (CRD.B) is expected to report $0.23 for Q3 2024 Aris Water Solutions Inc. Class A (ARIS) is expected to report $0.27 for Q3 2024 First Pacific Bancorp (FPBC) is expected to report for Q3 2...